Phase III Trial Of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy In Hpv-Associated Oropharynx Cancer
Posted Date: May 15, 2019
- Investigator: Jordan Kharofa
- Type of Study: Drug
This study is to compare the good and bad effects of two standard treatments for head and neck cancer: radiation therapy and Cisplatin or radiation therapy and cetuximab. This study is being done in patients whose head and neck cancer was caused by HPV. Treatment will last approximately 6-8 weeks wi
Criteria:
Eligible Patients Must Have Cancer Of The Head And Neck
Keywords:
Head And Neck Cancer, Hpv, Mouth Cancer, Oropharynx Cancer, R1016
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu